Sweta Chekuri

ORCID: 0000-0003-2123-1951
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Venous Thromboembolism Diagnosis and Management
  • Long-Term Effects of COVID-19
  • COVID-19 and healthcare impacts
  • Hepatitis C virus research
  • Pneumothorax, Barotrauma, Emphysema
  • Airway Management and Intubation Techniques
  • Liver Disease Diagnosis and Treatment
  • Respiratory Support and Mechanisms
  • Mycobacterium research and diagnosis
  • Respiratory viral infections research
  • Tuberculosis Research and Epidemiology
  • Intensive Care Unit Cognitive Disorders
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Diverticular Disease and Complications
  • Clinical Nutrition and Gastroenterology
  • Sepsis Diagnosis and Treatment
  • Biliary and Gastrointestinal Fistulas
  • Diabetes and associated disorders
  • Hepatitis B Virus Studies
  • Diagnosis and treatment of tuberculosis
  • Blood groups and transfusion
  • Autoimmune and Inflammatory Disorders
  • Frailty in Older Adults
  • Eosinophilic Esophagitis

National Heart Lung and Blood Institute
2023

Montefiore Medical Center
2020-2021

University Health Network
2021

St. Michael's Hospital
2021

Health Sciences Centre
2021

Sunnybrook Health Science Centre
2021

St. Boniface Hospital
2021

Royal Victoria Regional Health Centre
2021

St Michael’s Hospital
2021

University of Manitoba
2021

Ewan C. Goligher Charlotte Bradbury Bryan J. McVerry Patrick R. Lawler Jeffrey S. Berger and 95 more Michelle N. Gong Marc Carrier Harmony R. Reynolds Anand Kumar Alexis F. Turgeon Lucy Z. Kornblith Susan R. Kahn John C. Marshall Keri S. Kim Brett L. Houston Lennie Derde Mary Cushman Tobias Tritschler Derek Angus Lucas C. Godoy Zoe McQuilten Bridget‐Anne Kirwan Michael E. Farkouh Maria M. Brooks Roger Lewis Lindsay R. Berry Elizabeth Lorenzi Anthony Gordon Tania Ahuja Farah Al-Beidh Djillali Annane Yaseen M. Arabi Diptesh Aryal Lisa Baumann Kreuziger Abi Beane Zahra Bhimani Shailesh Bihari Henny H. Billett Lindsay Bond Marc J. M. Bonten Frank Brunkhorst Meredith Buxton Adrian Buzgau Lana A. Castellucci Sweta Chekuri Jen‐Ting Chen Allen C. Cheng Tamta Chkhikvadze Benjamin Coiffard Aira Contreras Todd W. Costantini Sophie de Brouwer Michelle A. Detry Abhijit Duggal Vladimír Džavík Mark B. Effron Heather Eng Jorge Escobedo Lise J Estcourt Brendan M. Everett Dean Fergusson Mark Fitzgerald Robert Fowler Joshua D. Froess Zhuxuan Fu J.‐P. Galanaud Benjamin Galen Sheetal Gandotra Timothy D. Girard Andrew L. Goodman Herman Goossens Cameron Green Yonatan Greenstein Peter L. Gross Rashan Haniffa Sheila M. Hegde Carolyn M. Hendrickson Alisa M. Higgins Alexander Hindenburg Aluko A. Hope James M Horowitz Christopher M. Horvat David T. Huang Kristin Hudock Beverley J. Hunt Mansoor Husain Robert C. Hyzy Jeffrey R. Jacobson Devachandran Jayakumar Norma Keller Akram Khan Yuri Kim Andrei Kindzelski Andrew J. King M. Margaret Knudson Aaron E. Kornblith Matthew Kutcher Michael Laffan François Lamontagne Grégoire Le Gal

Thrombosis and inflammation may contribute to morbidity mortality among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation would improve outcomes in critically ill Covid-19.

10.1056/nejmoa2103417 article EN New England Journal of Medicine 2021-08-04
Patrick R. Lawler Ewan C. Goligher Jeffrey S. Berger Matthew D. Neal Bryan J. McVerry and 95 more José Carlos Nicolau Michelle N. Gong Marc Carrier Robert S Rosenson Harmony R. Reynolds Alexis F. Turgeon Jorge Escobedo David T. Huang Charlotte Bradbury Brett L. Houston Lucy Z. Kornblith Anand Kumar Susan R. Kahn Mary Cushman Zoe McQuilten Arthur S. Slutsky Keri S. Kim Anthony Gordon Bridget‐Anne Kirwan Maria M. Brooks Alisa M. Higgins Roger Lewis Elizabeth Lorenzi Scott Berry Lindsay R. Berry Aaron W. Aday Farah Al-Beidh Djillali Annane Yaseen M. Arabi Diptesh Aryal Lisa Baumann Kreuziger Abi Beane Zahra Bhimani Shailesh Bihari Henny H. Billett Lindsay Bond Marc J. M. Bonten Frank Brunkhorst Meredith Buxton Adrian Buzgau Lana A. Castellucci Sweta Chekuri Jen‐Ting Chen Allen C. Cheng Tamta Chkhikvadze Benjamin Coiffard Todd W. Costantini Sophie de Brouwer Lennie Derde Michelle A. Detry Abhijit Duggal Vladimír Džavík Mark B. Effron Lise J Estcourt Brendan M. Everett Dean Fergusson Mark Fitzgerald Robert Fowler J.‐P. Galanaud Benjamin Galen Sheetal Gandotra Sebastián García‐Madrona Timothy D. Girard Lucas C. Godoy Andrew L. Goodman Herman Goossens Cameron Green Yonatan Greenstein Peter L Gross Naomi M. Hamburg Rashan Haniffa George P. Hanna Nicholas Hanna Sheila M. Hegde Carolyn M. Hendrickson R. Duncan Hite Alexander Hindenburg Aluko A. Hope James M Horowitz Christopher M. Horvat Kristin Hudock Beverley J. Hunt Mansoor Husain Robert C. Hyzy Vivek N. Iyer Jeffrey R. Jacobson Devachandran Jayakumar Norma Keller Akram Khan Yuri Kim Andrei Kindzelski Andrew J. King M. Margaret Knudson Aaron E. Kornblith Vidya Krishnan

Thrombosis and inflammation may contribute to the risk of death complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation improve outcomes in noncritically ill who are hospitalized Covid-19.In this open-label, adaptive, multiplatform, controlled trial, we randomly assigned were Covid-19 not critically (which was defined as an absence critical care-level organ support at enrollment) receive pragmatically regimens either...

10.1056/nejmoa2105911 article EN New England Journal of Medicine 2021-08-04
Ewan C. Goligher Patrick R. Lawler Thomas P. Jensen Victor B. Talisa Lindsay R. Berry and 95 more Elizabeth Lorenzi Bryan J. McVerry Chung‐Chou Ho Chang Eric Leifer Charlotte Bradbury Jeffrey S. Berger B. J. Hunt Lana A. Castellucci Lucy Z. Kornblith Anthony Gordon Colin McArthur Steven A. Webb Judith S. Hochman Matthew D. Neal Ryan Zarychanski Scott Berry Derek Angus Aaron W. Aday Tania Ahuja Farah Al-Beidh Derek Angus Djillali Annane Yaseen M. Arabi Diptesh Aryal Lisa Baumann Kreuziger Abigail Beane Jeffrey S. Berger Scott Berry Lindsay R. Berry Zahra Bhimani Shailesh Bihari Henny H. Billett Lindsay Bond Marc J. M. Bonten Charlotte Bradbury Maria M. Brooks Frank Brunkhorst Meredith Buxton Adrian Buzgau Marc Carrier Lana A. Castelucci Sweta Chekuri Jen‐Ting Chen Allen C. Cheng Tamta Chkhikvadze Benjamin Coiffard Aira Contreras Todd W. Costantini Mary Cushman Sophie de Brouwer Lennie Derde Michelle A. Detry Abhijit Duggal Vladimír Džavík Mark B. Effron Heather Eng Jorge Escobedo Lise J Estcourt Brendan M. Everett Micheal E. Farkough Dean Fergusson Mark Fitzgerald Rob Fowler Joshua D. Froess Zhuxuan Fu J.‐P. Galanaud Benjamin Galen Sheetal Gandotra Timothy D. Girard Lucus D. Godoy Ewan C. Goligher Michelle N. Gong Andrew L. Goodman Herman Goossens Anthony Gordon Cameron Green Yonatan Greenstein Peter L. Gross Raquel Morillo Guerrero Naomi M. Hamburg Rashan Haniffa George P. Hanna Nicholas Hanna Sheila M. Hedge Carolyn M. Hendrickson Alisa M. Higgins Alexander Hindenburg R. Duncan Hite Judith S. Hochman Aluko A. Hope James M Horowitz Christopher M. Horvat Brett L. Houston David T. Huang Kristin Hudock

Importance Randomized clinical trials (RCTs) of therapeutic-dose heparin in patients hospitalized with COVID-19 produced conflicting results, possibly due to heterogeneity treatment effect (HTE) across individuals. Better understanding HTE could facilitate individualized decision-making. Objective To evaluate for and compare approaches assessing HTE. Design, Setting, Participants Exploratory analysis a multiplatform adaptive RCT vs usual care pharmacologic thromboprophylaxis 3320 enrolled...

10.1001/jama.2023.3651 article EN JAMA 2023-03-21
Andrew J. Admon Theodore J. Iwashyna Lee A. Kamphuis Stephanie J. Gundel Sarina K. Sahetya and 95 more Ithan D. Peltan Steven Y. Chang Jin H. Han Kelly C. Vranas Kirby P. Mayer Aluko A. Hope Sarah E. Jolley Ellen Caldwell Max Monahan Katrina Hauschildt Samuel M. Brown Neil R. Aggarwal Bruce Thompson Catherine L. Hough Francois Abi Fadel Michael S. Aboodi Samuel Acquah Jason Y. Adams Neil R. Aggarwal Narendrakumar Alappan Timothy E. Albertson Mohammed Al‐Jaghbeer Eyad Almasri James S. Andrews Derek Angus Jason V. Baker Rebecca M. Baron Michaël Baumann Torben K. Becker Michelle Biehl Billie Bixby Joseph Bledsoe John W. Bloom Somnath Bose Katherine L. Boyle Patrick J. Bradley Rich D Branson Samuel M. Brown Ellen L. Burnham Carolyn S. Calfee Sean J. Callahan Alessandro Cancelliere Shannon S. Carson Jonathan D. Casey Steven Y. Chang Sweta Chekuri Peter Chen Tina Chen James Chenoweth Philip J. Choi Ivan Co Sean P. Collins Ana Carolina Monteiro Mick P. Couper Christopher E. Cox Jonathan Daich Marjolein de Wit Ben P deBoisblanc Matthew Dettmer Sandipan Dhar David Dillon Sarah B. Doernberg Pratik Doshi Ivor S. Douglas Brian E. Driver Siddharth Dugar Abhijit Duggal Marie‐Carmelle Elie Kyle B. Enfield John Eppensteiner Daniel Fein Michael R. Filbin Clark Files James H. Finigan Alexander H. Flannery Andrea S. Foulkes Alpha A. Fowler Adam Frisch Monica Fung J Gaillard James Galbraith Sheetal Gandotra Jayna Gardner-Gray Elizabeth A Gay Kevin W. Gibbs Evanpaul Gill Adit A. Ginde Timothy D. Girard Pauline H. Go Neha Goel Ewan C. Goligher Jose Gomez‐Arroyo Michelle N. Gong Andrew J. Goodwin Richard D. Gordon

Importance Individuals who survived COVID-19 often report persistent symptoms, disabilities, and financial consequences. However, national longitudinal estimates of symptom burden remain limited. Objective To measure the incidence changes over time in disability, status after COVID-19–related hospitalization. Design, Setting, Participants A US multicenter prospective cohort study with 1-, 3-, 6-month postdischarge visits was conducted at 44 sites participating National Heart, Lung, Blood...

10.1001/jamanetworkopen.2022.55795 article EN cc-by-nc-nd JAMA Network Open 2023-02-14

Background and Aim To investigate the impact of a sustained virological response (SVR) to hepatitis C virus (HCV) treatment on liver stiffness (LS). Methods LS, measured by transient elastography (FibroScan), demographic laboratory data patients treated with interferon (IFN)-containing or IFN-free regimens who had an SVR24 (undetectable HCV viral load 24 weeks after end treatment) were analyzed using two-tailed paired t-tests, Mann-Whitney Wilcoxon Signed-rank tests linear regression. Two...

10.1371/journal.pone.0159413 article EN cc-by PLoS ONE 2016-07-21

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome 2 (SARS-CoV-2) claimed over 4 million lives July 2021 and continues to pose a serious public health threat.Our retrospective study utilized pathogen panel (RPP) results in patients with SARS-CoV-2 determine if coinfection (i.e. positivity an additional virus) was associated more presentation outcomes.All negative influenza/respiratory syncytial virus testing who underwent RPP within 7 days of...

10.1093/jac/dkab244 article EN cc-by-nc Journal of Antimicrobial Chemotherapy 2021-07-08

Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has a variable clinical course with significant mortality. Early reports suggested higher rates of SARS‐CoV‐2 infection in patients type A blood and enrichment individuals among COVID‐19 mortalities. Study Design Methods The study includes all hospitalized or an emergency department (ED) visit who were tested for between March 10, 2020 June 8, had positive test result by nucleic acid (NAT) performed on...

10.1111/trf.16339 article EN other-oa Transfusion 2021-03-05

Novel coronavirus disease 2019 (COVID-19) is increasingly recognized as a prothrombotic state with high incidence of thrombotic complications, particularly in patients severe clinical course [1,2]. However, 70–81% COVID-19 cases are associated non-severe and recover supportive care [3,4]. The few studies that exist estimate the venous thromboembolism (VTE) risk among general medical wards to be between 5 10%, which strikingly lower than 30% seen ICU [1,5–7].

10.1016/j.thromres.2020.12.023 article EN other-oa Thrombosis Research 2020-12-26

To determine the association between prone positioning in nonintubated patients with coronavirus disease 2019 and frequency of invasive mechanical ventilation or inhospital mortality.

10.1097/cce.0000000000000348 article EN cc-by-nc-nd Critical Care Explorations 2021-02-01

Purpose: Esophagitis dissecans superficialis (EDS) is a benign, rare lesion characterized by esophageal mucosal epithelium sloughing. It has no clear etiologic cause, although it been associated with pemphigus vulgaris, ingestion of bisphosphonates, rigid endoscopy, celiac disease and accidental fish bone. We present patient classic findings EDS, in whom HIV may play role. Case Report: A 58-year-old white male controlled medication suffered fall at home. He had head injury without loss...

10.14309/00000434-201210001-00581 article EN The American Journal of Gastroenterology 2012-10-01

Introduction: Early enteral nutrition (EEN) is a therapeutic strategy that used in critical illness to reduce morbidity and mortality. There no data on the role of therapy for intubated critically ill COVID-19 patients. The aim our study was assess if early reduced mortality during first wave pandemic. Methods: A retrospective chart review patients >18 years who were mechanically ventilated >48 hours at Montefiore Medical Center from March 2020 November (n = 669) performed. Using landmark...

10.14309/01.ajg.0000779252.47675.af article EN The American Journal of Gastroenterology 2021-10-01

Introduction: Acute diverticulitis occurs when fecal matter obstructs the orifice of a diverticulum and local infection ensues. Inflammation can result in reduced tissue perfusion leading to focal necrosis perforation. A small perforation may be walled off by omentum present as localized abscess. Disruption vascular integrity siphoning gas into system. Rarely intravascular leads thrombosis septic emboli. Case Report: We are reporting an interesting case 54-year-old male with history alcohol...

10.14309/00000434-201210001-01209 article EN The American Journal of Gastroenterology 2012-10-01

Rationale: Prone positioning is a well-established recruitment maneuver to improve oxygenation and decrease mortality in intubated patients with severe acute respiratory distress syndrome (ARDS). There evolving literature utilizing proning among non-intubated hypoxemic novel coronavirus 2019 (COVID-19). However, there paucity of evidence proving sustained improvement patient-centered outcomes. We aimed determine the association between prone COVID-19 incidence invasive mechanical ventilation...

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2488 article EN 2021-05-01

Abstract Introduction: Coronavirus Disease 2019 (COVID-19) deaths have surpassed one million worldwide with limited treatment modalities, and physicians are relying on alternative methods, such as Vitamin D supplementation, to prevent or halt disease progression without direct evidence. Research has proven that vitamin supplementation can inflammation based its role in innate immune response; however, there been studies regarding COVID-19. We aimed determine whether insufficient patients was...

10.1210/jendso/bvab048.567 article EN cc-by-nc-nd Journal of the Endocrine Society 2021-05-01
Coming Soon ...